Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Interest & Investment Income of $8000.0 for Q1 2026, up 125.81% on a QoQ basis from -$31000.0 in Q3 2025, and up 109.88% year-over-year from $3811.8 in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Interest & Investment Income history runs 14 years deep, the most recent figure standing at $8000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 109.88% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25000.0 (up 247.06% YoY) and the FY2025 annual result came in at -$64000.0, down 228.0% from the prior year.
- Interest & Investment Income was $8000.0 for Q1 2026 at Catalyst Pharmaceuticals, up from -$31000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $323000.0 in Q2 2022 and bottomed at -$305000.0 in Q1 2022.
- A 5-year average of $11142.9 and a median of -$2500.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 6500.0% — and 2025, when it sank 478.57%.
- Catalyst Pharmaceuticals' Interest & Investment Income stood at -$8000.0 in 2022, then jumped by 87.5% to -$1000.0 in 2023, then surged by 6500.0% to $64000.0 in 2024, then slumped by 148.44% to -$31000.0 in 2025, then surged by 125.81% to $8000.0 in 2026.
- Business Quant data shows CPRX's Interest & Investment Income at $8000.0 in Q1 2026, -$31000.0 in Q3 2025, and $48000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Sep 30, 2025 | -31,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | -8,000.00 |
| Sep 30, 2022 | 162,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | -305,000.00 |
| Dec 31, 2021 | -85,000.00 |
| Sep 30, 2021 | -26,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Mar 31, 2021 | -76,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Sep 30, 2020 | -5,000.00 |